SafER Medical Products Inc, is pleased to announce a new private placement funding opportunity for accredited investors. As detailed in the Private Placement Memorandum (PPM), this offering will raise a total of $10 million, with the proceeds targeted to fuel SafER’s next stage of rapid growth. The offering is only open to Accredited Investors as defined by the SEC and the nominal minimum investment is $100,000.
Since our inception in July 2020, SafER has been on a mission to promote and establish SafER Portable Negative Pressure Systems (PNPS) within the healthcare industry to provide a safe work environment for emergency medical workers, respiratory therapists, caregivers, medical staff and patients. Safer is the Nebulizer of the future and will radically transform respiratory care. It is already being used in ERs, helicopters, ambulances and senior facilities.
SafER Medical’s Respiratory Shield and Endoshield systems are easy to use, lightweight, and small enough to fit seamlessly into any size workspace. At a tiny fraction of the cost of the current medical care standard for airborne respiratory illness, the revolutionary SafER system is 99.99% effective in preventing infected airborne particles from spreading.
The SafER system has worldwide application. There is no health care facility in the world that could not use the SafER Device. There is no ambulance, prison, doctor’s office, dialysis center, nursing home, chemotherapy/radiation clinic, government disaster cache or military unit that could not benefit from containing airborne illnesses.
For more information on the private placement offering and to obtain a copy of the PPM, contact Carl Baker, SafER CEO, at cbaker@safermedicalproducts.com